Inventor profile of:

Johan Neyts

City:

Leuven

Country:

Belgium

Published Applications:

15

Last publication date:

2022-04-07

Top Assignees for applications by Johan Neyts

The entities that hold a legal rights for patent applications filed by inventor Neyts Johan:

Recent patent applications by Neyts Johan

Johan Neyts from Leuven, BE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-04-07
US20220106321A1
Chemistry; metallurgy

Viral replication inhibitors

#2 | 2020-07-16
US20200223845A1
Chemistry; metallurgy

Viral replication inhibitors

#3 | 2019-11-07
US20190337954A1
Chemistry; metallurgy

Viral replication inhibitors

#4 | 2019-07-04
US20190201352A1
Human necessities

DESIGN, SYNTHESIS AND METHODS OF USE OF ACYCLIC FLEXMIER NUCLEOSIDE ANALOGUES HAVING ANTI-CORONAVIRUS ACTIVITY

#5 | 2019-04-18
US20190111125A1
Human necessities

BACTERIAL ARTIFICIAL CHROMOSOMES

#6 | 2018-10-25
US20180303768A1
Human necessities

Design, synthesis and methods of use of acyclic fleximer nucleoside analogues having anti-coronavirus activity

#7 | 2018-01-18
US20180015052A1
Human necessities

Design, synthesis and methods of use of acyclic fleximer nucleoside analogues having anti-coronavirus activity

#8 | 2016-10-13
US20160297810A1
Chemistry; metallurgy

Viral replication inhibitors

#9 | 2016-07-21
US20160206723A1
Human necessities

Bacterial artificial chromosomes

#10 | 2016-02-04
US20160030447A1
Human necessities

Antiviral activity of novel bicyclic heterocycles

#11 | 2015-01-29
US20150030563A1
Human necessities

Compound for the Treatment of Enteroviruses

#12 | 2014-07-31
US20140213586A1
Chemistry; metallurgy

Viral replication inhibitors

#13 | 2013-07-25
US20130190297A1
Chemistry; metallurgy

Antiviral activity of bicyclic heterocycles

#14 | 2012-01-26
US20120022073A1
Human necessities

Compound for the treatment of enteroviruses

#15 | 2011-05-26
US20110124592A1
Chemistry; metallurgy

Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of hepatitis C virus

InventorID:

355607 ⎘